Related Experiment Videos
Interpreting cancer vaccine clinical trials
1Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. glenn-dranoff@dfci.harvard.edu
The Journal of Gene Medicine
|March 30, 2000
Abstract:
A number of cancer vaccine strategies have entered initial Phase I clinical testing. In this review, Dr. Glenn Dranoff discusses the prospects that appropriate immunologic monitoring of patients in these trials can help delineate important differences among the various immunization strategies and prioritize the most promising approaches for further clinical development.